SML1132
Pep2-8 trifluoroacetate salt
≥95% (HPLC), contains 58μL of solution at 10mM in DMSO
別名:
Ac-TVFTSWEEYLDWV-NH2 trifluoroacetate salt, Ac-TVFTSWEEYLDWV-amide trifluoroacetate salt, Ac-Thr-Val-Phe-Thr-Ser-Trp-Glu-Glu-Tyr-Leu-Asp-Trp-Val-NH2 trifluoroacetate salt
ログイン組織・契約価格を表示する
すべての画像(1)
サイズを選択してください
表示を変更する
1 MG
¥30,400
About This Item
実験式(ヒル表記法):
C83H110N16O24 · xC2HF3O2
分子量:
1715.85 (free base basis)
UNSPSCコード:
12352200
NACRES:
NA.77
おすすめの製品
アッセイ
≥95% (HPLC)
フォーム
solution
色
colorless to pale yellow
輸送温度
wet ice
保管温度
−20°C
Amino Acid Sequence
Ac-Thr-Val-Phe-Thr-Ser-Trp-Glu-Glu-Tyr-Leu-Asp-Trp-Val-NH2 trifluoroacetate salt
生物化学的/生理学的作用
Pep2-8 is a potent PCSK9 (proprotein convertase subtilisin/kexin type 9) inhibitor that selectively binds to PCSK9 and interferes with LDL receptor binding to PCSK9. Pep2-8 restores LDL receptor function and LDL uptake of PCSK9-treated HepG2 cells.
Pep2-8 is a potent PCSK9 (proprotein convertase subtilisin/kexin type 9) inhibitor.
Pep2-8, a good mimic of epidermal growth factor precursor homology domain A (EGF-A)[1], serves as a competitive inhibitor of low-density lipoprotein (LDL) receptor binding.[2] It can be used as an anchor peptide in phage-display experiments to bind an extension peptide library to the groove site.[1]
保管分類コード
11 - Combustible Solids
WGK
WGK 3
引火点(°F)
Not applicable
引火点(℃)
Not applicable
最新バージョンのいずれかを選択してください:
Yingnan Zhang et al.
The Journal of biological chemistry, 289(2), 942-955 (2013-11-15)
PCSK9 (proprotein convertase subtilisin/kexin type 9) is a negative regulator of the hepatic LDL receptor, and clinical studies with PCSK9-inhibiting antibodies have demonstrated strong LDL-c-lowering effects. Here we screened phage-displayed peptide libraries and identified the 13-amino acid linear peptide Pep2-8
Yingnan Zhang et al.
Nature structural & molecular biology, 24(10), 848-856 (2017-08-22)
Proprotein convertase subtilisin/kexin type 9 (PCSK9) regulates plasma LDL cholesterol (LDL-c) levels by promoting the degradation of liver LDL receptors (LDLRs). Antibodies that inhibit PCSK9 binding to the EGF(A) domain of the LDLR are effective in lowering LDL-c. However, the
アクティブなフィルタ
ライフサイエンス、有機合成、材料科学、クロマトグラフィー、分析など、あらゆる分野の研究に経験のあるメンバーがおります。.
製品に関するお問い合わせはこちら(テクニカルサービス)